[Effect of prostaglandin family on peripheral vascular system].
Yano
T
T
First Department of Surgery, Nagoya University School of Medicine.
D000527:Alprostadil / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D015118:Eicosapentaenoic Acid / Q000494:pharmacology / Q000627:therapeutic use; D011464:Epoprostenol / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins / Q000502:physiology*; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents
D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol; D000527:Alprostadil